NSCLC Biomarkers: Expert Insights on New Targets, Testing Options, and Personalized Treatment

Review expert guidance for oncologists and pathologists on testing for new and emerging predictive biomarkers to guide treatment of NSCLC with this on-demand Webcast and slides from a live CCO Webinar.

Share

Program Content

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Merck Sharp & Dohme Corp.